{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:20:56Z","timestamp":1787764856974,"version":"build-2784847793"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006458","name":"Children's Hospital of Philadelphia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006458","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.modpat.2024.100661","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T17:45:03Z","timestamp":1732124703000},"page":"100661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Congenital Peribronchial Myofibroblastic Tumors Harbor a Recurrent EGFR Kinase Domain Duplication"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8961-3043","authenticated-orcid":false,"given":"Sheren","family":"Younes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Pogoriler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raya","family":"Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea F.","family":"Surrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5409-0695","authenticated-orcid":false,"given":"Serena Y.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.modpat.2024.100661_bib1","first-page":"150","article-title":"Unusual hamartoma of the lung in a newborn infant","volume":"48","author":"Jones","year":"1949","journal-title":"Arch Pathol (Chic)"},{"issue":"591","key":"10.1016\/j.modpat.2024.100661_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1259\/0007-1285-50-591-217","article-title":"Congenital mesenchymal tumour of the lung","volume":"50","author":"Haller","year":"1977","journal-title":"Br J Radiol"},{"issue":"2-4","key":"10.1016\/j.modpat.2024.100661_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/15513818509078792","article-title":"Massive congenital mesenchymal malformation of the lung: a case report with ultrastructural study","volume":"3","author":"Warren","year":"1985","journal-title":"Pediatr Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2024.100661_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2559.1990.tb01170.x","article-title":"Massive congenital mesenchymal malformation of the lung: another cause of non-immune hydrops","volume":"16","author":"Khong","year":"1990","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.modpat.2024.100661_bib5","first-page":"348","article-title":"Primary bronchopulmonary leiomyosarcoma in childhood","volume":"110","author":"Jimenez","year":"1986","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.modpat.2024.100661_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0046-8177(89)90012-9","article-title":"Primary bronchopulmonary fibrosarcoma of childhood and adolescence: reassessment of a low-grade malignancy. Clinicopathologic study of five cases and review of the literature","volume":"20","author":"Pettinato","year":"1989","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100661_bib7","first-page":"487","article-title":"Congenital peribronchial myofibroblastic tumor (so-called \u201ccongenital leiomyosarcoma\u201d). A distinct neonatal lung lesion associated with nonimmune hydrops fetalis","volume":"6","author":"McGinnis","year":"1993","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2024.100661_bib8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1447-0756.2005.00335.x","article-title":"Fetal hydrops associated with congenital pulmonary myofibroblastic tumor","volume":"31","author":"Horikoshi","year":"2005","journal-title":"J\u00a0Obstet Gynaecol Res"},{"issue":"4","key":"10.1016\/j.modpat.2024.100661_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/pin.12141","article-title":"Congenital peribronchial myofibroblastic tumor","volume":"64","author":"Hotokebuchi","year":"2014","journal-title":"Pathol Int"},{"issue":"4","key":"10.1016\/j.modpat.2024.100661_bib10","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.radcr.2024.01.002","article-title":"Prenatal features of congenital peribronchial myofibroblastic tumor","volume":"19","author":"Isohata","year":"2024","journal-title":"Radiol Case Rep"},{"issue":"3","key":"10.1016\/j.modpat.2024.100661_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5152\/balkanmedj.2013.8373","article-title":"Congenital peribronchial myofibroblastic tumor: a case report and review of the literature","volume":"30","author":"A\u00e7\u0131kal\u0131n","year":"2013","journal-title":"Balk Med J"},{"issue":"1","key":"10.1016\/j.modpat.2024.100661_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12887-023-04001-5","article-title":"Congenital peribronchial myofibroblastic tumor (CPMT): a case report with long term follow-up and next-generation sequencing (NGS)","volume":"23","author":"Zhou","year":"2023","journal-title":"BMC Pediatr"},{"issue":"11","key":"10.1016\/j.modpat.2024.100661_bib13","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/pd.1293","article-title":"Congenital pulmonary myofibroblastic tumor--pathology and prenatal sonographic appearance","volume":"25","author":"Reiss","year":"2005","journal-title":"Prenat Diagn"},{"issue":"42","key":"10.1016\/j.modpat.2024.100661_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001842","article-title":"A\u00a0congenital peribronchial myofibroblastic tumor detected in a premature infant at 28 weeks but that resolved in the late stage of pregnancy: a case report","volume":"94","author":"Xia","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.modpat.2024.100661_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2350\/09-12-0767-CR.1","article-title":"Congenital peribronchial myofibroblastic tumor: comparison of fetal and postnatal morphology","volume":"14","author":"Huppmann","year":"2011","journal-title":"Pediatr Dev Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100661_bib16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00000478-199705000-00016","article-title":"Congenital pulmonary myofibroblastic tumor: a case report with cytogenetic analysis and review of the literature","volume":"21","author":"Alobeid","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100661_bib17","first-page":"83","article-title":"Congenital peribronchial myofibroblastic tumor: case report of an asymptomatic infant with a rapidly enlarging pulmonary mass and review of the literature","volume":"45","author":"Brock","year":"2015","journal-title":"Ann Clin Lab Sci"},{"issue":"2","key":"10.1016\/j.modpat.2024.100661_bib18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4132\/KoreanJPathol.2013.47.2.172","article-title":"Congenital peribronchial myofibroblastic tumor: a case study and literature review","volume":"47","author":"Kim","year":"2013","journal-title":"Korean J Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100661_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30042","article-title":"A\u00a0rare case of congenital peribronchial myofibroblastic tumor in a Chinese infant","volume":"70","author":"Zhang","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.modpat.2024.100661_bib20","series-title":"WHO Classification of Tumours Editorial Board. Paediatric Tumours (WHO Classification of Tumors Series)","article-title":"Congenital peribronchial myofibroblastic tumour","author":"Vargas","year":"2022"},{"issue":"5","key":"10.1016\/j.modpat.2024.100661_bib21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jmoldx.2019.05.006","article-title":"Development and clinical validation of a large fusion gene panel for pediatric cancers","volume":"21","author":"Chang","year":"2019","journal-title":"J\u00a0Mol Diagn"},{"issue":"1","key":"10.1016\/j.modpat.2024.100661_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13073-019-0644-8","article-title":"Clinical utility of custom-designed NGS panel testing in pediatric tumors","volume":"11","author":"Surrey","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.modpat.2024.100661_bib23","article-title":"Development and clinical validation of a targeted RNAseq panel (Fusion-STAMP) for diagnostic and predictive gene fusion detection in solid tumors","author":"Nohr","year":"2019","journal-title":"Preprint"},{"issue":"11","key":"10.1016\/j.modpat.2024.100661_bib24","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1007\/s00247-018-4174-0","article-title":"The rare solid fetal lung lesion with T2-hypointense components: prenatal imaging findings with postnatal pathological correlation","volume":"48","author":"Victoria","year":"2018","journal-title":"Pediatr Radiol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100661_bib25","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/s41467-021-21613-6","article-title":"Structure-function analysis of oncogenic EGFR kinase domain duplication reveals insights into activation and a potential approach for therapeutic targeting","volume":"12","author":"Du","year":"2021","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.modpat.2024.100661_bib26","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/2159-8290.CD-15-0654","article-title":"EGFR kinase domain duplication (EGFR-KDD) is a novel oncogenic driver in lung cancer that is clinically responsive to afatinib","volume":"5","author":"Gallant","year":"2015","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.modpat.2024.100661_bib27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/his.14194","article-title":"Congenital mesoblastic nephroma is characterised by kinase mutations including EGFR internal tandem duplications, the ETV6-NTRK3 fusion, and the rare KLHL7-BRAF fusion","volume":"77","author":"Zhao","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2024.100661_bib28","article-title":"Recurrent EGFR alterations in NTRK3 fusion negative congenital mesoblastic nephroma","volume":"21","author":"Lei","year":"2020","journal-title":"Pract Lab Med"},{"issue":"1","key":"10.1016\/j.modpat.2024.100661_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/gcc.23087","article-title":"EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors","volume":"62","author":"Koo","year":"2023","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.modpat.2024.100661_bib30","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/QAD.0b013e3283389e26","article-title":"Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings","volume":"24","author":"Vispo","year":"2010","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.modpat.2024.100661_bib31","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1097\/PAS.0000000000001297","article-title":"Spindle cell tumors with RET gene fusions exhibit a morphologic spectrum akin to tumors with NTRK gene fusions","volume":"43","author":"Antonescu","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2024.100661_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26437","article-title":"Congenital mesoblastic nephroma 50 years after its recognition: a narrative review","volume":"64","author":"Gooskens","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.modpat.2024.100661_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26925","article-title":"ETV6-NTRK3 in congenital mesoblastic nephroma: a report of the SIOP\/GPOH nephroblastoma study","volume":"65","author":"Vokuhl","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"25","key":"10.1016\/j.modpat.2024.100661_bib34","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1016\/j.cell.2022.11.005","article-title":"A\u00a0human fetal lung cell atlas uncovers proximal-distal gradients of differentiation and key regulators of epithelial fates","volume":"185","author":"He","year":"2022","journal-title":"Cell"},{"issue":"6460","key":"10.1016\/j.modpat.2024.100661_bib35","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.aat5031","article-title":"Spatiotemporal immune zonation of the human kidney","volume":"365","author":"Stewart","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.modpat.2024.100661_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.671402","article-title":"Organ-specific branching morphogenesis","volume":"9","author":"Lang","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"10.1016\/j.modpat.2024.100661_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187118","article-title":"The human kidney capsule contains a functionally distinct mesenchymal stromal cell population","volume":"12","author":"Leuning","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.modpat.2024.100661_bib38","first-page":"380","article-title":"Congenital spindle-cell neoplasms of the intestine: a case report and literature review","volume":"7","author":"Sherman","year":"1985","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"11","key":"10.1016\/j.modpat.2024.100661_bib39","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00383-017-4149-5","article-title":"Recurrent and metastatic congenital mesoblastic nephroma: where does the evidence stand?","volume":"33","author":"Jehangir","year":"2017","journal-title":"Pediatr Surg Int"},{"issue":"2","key":"10.1016\/j.modpat.2024.100661_bib40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng0298-184","article-title":"A\u00a0novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma","volume":"18","author":"Knezevich","year":"1998","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.modpat.2024.100661_bib41","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0002-9440(10)65732-X","article-title":"Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma","volume":"153","author":"Rubin","year":"1998","journal-title":"Am J Pathol"},{"issue":"22","key":"10.1016\/j.modpat.2024.100661_bib42","first-page":"5046","article-title":"ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma","volume":"58","author":"Knezevich","year":"1998","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.modpat.2024.100661_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/his.14443","article-title":"Mesenchymal neoplasms with NTRK and other kinase gene alterations","volume":"80","author":"Davis","year":"2022","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.modpat.2024.100661_bib45","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1038\/s41467-018-04650-6","article-title":"Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants","volume":"9","author":"Wegert","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.modpat.2024.100661_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pathol.2015.11.007","article-title":"Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement","volume":"48","author":"El Demellawy","year":"2016","journal-title":"Pathology"},{"issue":"3","key":"10.1016\/j.modpat.2024.100661_bib47","first-page":"714","article-title":"Chromosome aberrations in mesoblastic nephroma","volume":"143","author":"Schofield","year":"1993","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100661_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/modpathol.3880006","article-title":"Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma\/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors","volume":"13","author":"Argani","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2024.100661_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2021.151885","article-title":"Infantile fibrosarcoma with an EGFR kinase domain duplication: underlining a close relationship with congenital mesoblastic nephroma and highlighting a similar morphological spectrum","volume":"57","author":"van Spronsen","year":"2022","journal-title":"Ann Diagn Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2024.100661_bib50","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/gcc.23067","article-title":"Tyrosine kinase-altered spindle cell neoplasms with EGFR internal tandem duplications","volume":"61","author":"Kao","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.modpat.2024.100661_bib51","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/15513815.2011.587497","article-title":"Unusual presentation of congenital infantile fibrosarcoma in seven infants with molecular-genetic analysis","volume":"30","author":"Steelman","year":"2011","journal-title":"Fetal Pediatr Pathol"},{"key":"10.1016\/j.modpat.2024.100661_bib52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejca.2023.04.007","article-title":"Afatinib in paediatric patients with recurrent\/refractory ErbB-dysregulated tumours: results of a phase I\/expansion trial","volume":"188","author":"Geoerger","year":"2023","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.modpat.2024.100661_bib53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11060-021-03763-1","article-title":"A\u00a0phase I\/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma","volume":"153","author":"El-Khouly","year":"2021","journal-title":"J\u00a0Neurooncol"},{"issue":"25","key":"10.1016\/j.modpat.2024.100661_bib54","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1200\/JCO.2005.11.429","article-title":"Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children\u2019s Oncology Group Study","volume":"23","author":"Daw","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"30","key":"10.1016\/j.modpat.2024.100661_bib55","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1200\/JCO.2007.15.2306","article-title":"Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children\u2019s Oncology Group Phase I Consortium Study","volume":"26","author":"Jakacki","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.modpat.2024.100661_bib56","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1016\/j.ejca.2010.07.005","article-title":"A\u00a0phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas","volume":"46","author":"Geyer","year":"2010","journal-title":"Eur J Cancer"},{"issue":"27","key":"10.1016\/j.modpat.2024.100661_bib57","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1200\/JCO.2010.28.4687","article-title":"Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study","volume":"28","author":"Fouladi","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100661_bib58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/neuonc\/noq141","article-title":"Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing\/refractory brain tumors","volume":"13","author":"Geoerger","year":"2011","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100661_bib59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11060-013-1166-7","article-title":"A\u00a0molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study","volume":"114","author":"Fouladi","year":"2013","journal-title":"J\u00a0Neurooncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224002412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224002412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T07:30:31Z","timestamp":1740641431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395224002412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0893395224002412"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100661","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Congenital Peribronchial Myofibroblastic Tumors Harbor a Recurrent EGFR Kinase Domain Duplication","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"100661"}}